Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Chatzopoulos

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Medicina (Kaunas, Lithuania)|February 25, 2022
<i>Ofeleein i mi Vlaptin</i>-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 PandemicJannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, et al.
Investigative Ophthalmology & Visual Science|January 14, 2026
Potential Influence of Helicobacter Pylori on Glaucoma-Related Alterations of Ocular Surface Microbiota and Dry Eye Disease PathophysiologyJannis Kountouras, Christos Zavos, Stergios A Polyzos, et al.
Surgical Endoscopy|August 23, 2011
Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinomaJannis Kountouras, Dimitrios Chatzopoulos, Christos Zavos, et al.
Clinical Immunology (Orlando, Fla.)|September 24, 2023
Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver diseaseJannis Kountouras, Evangelos Kazakos, Stergios A Polyzos, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbiditiesJannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, et al.
Annals of Gastroenterology|May 5, 2023
Innate immunity and nonalcoholic fatty liver diseaseJannis Kountouras, Evangelos Kazakos, Foteini Kyrailidi, et al.
Pathogens (Basel, Switzerland)|September 27, 2025
Detection of Pseudorabies Virus in Hunting Dogs in Greece: The Role of Wild Boars in Virus TransmissionKonstantinos Papageorgiou, Ilias Bouzalas, Kiriaki Giamoustari, et al.
Neurochemistry International|January 12, 2023
Impact of nonalcoholic fatty liver disease-related metabolic state on depressionSmaragda Ntona, Apostolis Papaefthymiou, Jannis Kountouras, et al.
Alimentary Pharmacology & Therapeutics|July 30, 2024
Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASHJannis Kountouras, Stergios A Polyzos, Evangelos Kazakos, et al.
Journal of Neurogastroenterology and Motility|July 7, 2023
Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse SyndromeJannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Medicina (Kaunas, Lithuania)|February 25, 2022
<i>Ofeleein i mi Vlaptin</i>-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 PandemicJannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, et al.
Investigative Ophthalmology & Visual Science|January 14, 2026
Potential Influence of Helicobacter Pylori on Glaucoma-Related Alterations of Ocular Surface Microbiota and Dry Eye Disease PathophysiologyJannis Kountouras, Christos Zavos, Stergios A Polyzos, et al.
Surgical Endoscopy|August 23, 2011
Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinomaJannis Kountouras, Dimitrios Chatzopoulos, Christos Zavos, et al.
Clinical Immunology (Orlando, Fla.)|September 24, 2023
Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver diseaseJannis Kountouras, Evangelos Kazakos, Stergios A Polyzos, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbiditiesJannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, et al.
Annals of Gastroenterology|May 5, 2023
Innate immunity and nonalcoholic fatty liver diseaseJannis Kountouras, Evangelos Kazakos, Foteini Kyrailidi, et al.
Pathogens (Basel, Switzerland)|September 27, 2025
Detection of Pseudorabies Virus in Hunting Dogs in Greece: The Role of Wild Boars in Virus TransmissionKonstantinos Papageorgiou, Ilias Bouzalas, Kiriaki Giamoustari, et al.
Neurochemistry International|January 12, 2023
Impact of nonalcoholic fatty liver disease-related metabolic state on depressionSmaragda Ntona, Apostolis Papaefthymiou, Jannis Kountouras, et al.
Alimentary Pharmacology & Therapeutics|July 30, 2024
Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASHJannis Kountouras, Stergios A Polyzos, Evangelos Kazakos, et al.
Journal of Neurogastroenterology and Motility|July 7, 2023
Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse SyndromeJannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, et al.
Pageof 9